Xiaoyun Si1, Ximing Liu2, Jingjing Li1, Xiaoyan Wu1. 1. Department of Nephrology, Zhongnan Hospital of Wuhan University Wuhan 430071, Hubei Province, P. R. China. 2. Department of Orthopaedics Surgery, Wuhan General Hospital of Guangzhou Command Wuhan 430070, Hubei Province, P. R. China.
Abstract
BACKGROUNDS: Acute ischemia reperfusion-induced kidney injury is a common cause of acute renal failure, and it is also an important cause of delayed recovery of transplanted kidney functions and even loss of function. However, there is no effective treatment method in clinical applications presently. OBJECTIVE: The objective was to investigate effects of transforming growth factor-β1 on homing of bone marrow mesenchymal stem cells in renal ischemia-reperfusion injury. METHODS: Effects of TGF-β1 over-expression in MSCs on expression of CXCR4 and chemotactic effect to SDF-1 were investigated by in vitro transmembrane chemotaxis. Anti-TGF-β1 antibody was incubated with ischemia reperfusion injury renal tissue homogenate and effects of anti-TGF-β1 antibody were observed. In addition, effects of TGF-β1 gene transfection and anti-CXCR4 antibody treatment in MSCs on expression of SDF-1/CXCR4 axis of renal tissues and damage repair were further explored. RESULTS: Expression of TGF-β1 mRNA in the IRI group increased significantly, and MSCs transplantation could enhance expression of CXCR4 mRNA in rats of the IRI group, the expression of CXCR4 can be decreased by the anti-TGF-β1 antibody and the anti-CXCR4 antibody. TGF-β1 induced homing of MSCs in repair of renal ischemic reperfusion injury by regulating expression of CXCR4 on cell membranes. Blue fluorescence of DAPI-positive MSCs cells of renal parenchyma in the IRI+MSC group was enhanced significantly, which was significantly inhibited by anti-TGF-β1 and anti-CXCR4 antibody, and the inhibitory effect of anti-CXCR4 antibody was more obvious than that of anti-TGF-β1 antibody. CONCLUSION: Transforming growth factor-β1 promotes homing of bone marrow mesenchymal stem cells in renal ischemia-reperfusion injury, which will provide useful data on role of TGF-β1 in regulating SDF-1/CXCR4 axis-induced MSCs homing.
BACKGROUNDS: Acute ischemia reperfusion-induced kidney injury is a common cause of acute renal failure, and it is also an important cause of delayed recovery of transplanted kidney functions and even loss of function. However, there is no effective treatment method in clinical applications presently. OBJECTIVE: The objective was to investigate effects of transforming growth factor-β1 on homing of bone marrow mesenchymal stem cells in renal ischemia-reperfusion injury. METHODS: Effects of TGF-β1 over-expression in MSCs on expression of CXCR4 and chemotactic effect to SDF-1 were investigated by in vitro transmembrane chemotaxis. Anti-TGF-β1 antibody was incubated with ischemia reperfusion injury renal tissue homogenate and effects of anti-TGF-β1 antibody were observed. In addition, effects of TGF-β1 gene transfection and anti-CXCR4 antibody treatment in MSCs on expression of SDF-1/CXCR4 axis of renal tissues and damage repair were further explored. RESULTS: Expression of TGF-β1 mRNA in the IRI group increased significantly, and MSCs transplantation could enhance expression of CXCR4 mRNA in rats of the IRI group, the expression of CXCR4 can be decreased by the anti-TGF-β1 antibody and the anti-CXCR4 antibody. TGF-β1 induced homing of MSCs in repair of renal ischemic reperfusion injury by regulating expression of CXCR4 on cell membranes. Blue fluorescence of DAPI-positive MSCs cells of renal parenchyma in the IRI+MSC group was enhanced significantly, which was significantly inhibited by anti-TGF-β1 and anti-CXCR4 antibody, and the inhibitory effect of anti-CXCR4 antibody was more obvious than that of anti-TGF-β1 antibody. CONCLUSION: Transforming growth factor-β1 promotes homing of bone marrow mesenchymal stem cells in renal ischemia-reperfusion injury, which will provide useful data on role of TGF-β1 in regulating SDF-1/CXCR4 axis-induced MSCs homing.
Authors: Katerina M Antoniou; Helen A Papadaki; Giannoula Soufla; Maria Christina Kastrinaki; Athina Damianaki; Helen Koutala; Demetrios A Spandidos; Nikolaos M Siafakas Journal: Respir Med Date: 2010-05-18 Impact factor: 3.415
Authors: Avital Mendelson; Eric Frank; Chad Allred; Elena Jones; Mo Chen; Wenli Zhao; Jeremy J Mao Journal: FASEB J Date: 2011-07-11 Impact factor: 5.191
Authors: Michael Quante; Shui Ping Tu; Hiroyuki Tomita; Tamas Gonda; Sophie S W Wang; Shigeo Takashi; Gwang Ho Baik; Wataru Shibata; Bethany Diprete; Kelly S Betz; Richard Friedman; Andrea Varro; Benjamin Tycko; Timothy C Wang Journal: Cancer Cell Date: 2011-02-15 Impact factor: 31.743
Authors: Mary Kearns-Jonker; Wangde Dai; Mirja Gunthart; Tania Fuentes; Hsiao-Yun Yeh; Paul Gerczuk; Martin Pera; Christine Mummery; Robert A Kloner Journal: J Stem Cell Res Ther Date: 2012-06-07
Authors: Andrea F Wise; Timothy M Williams; Mensiena B G Kiewiet; Natalie L Payne; Christopher Siatskas; Chrishan S Samuel; Sharon D Ricardo Journal: Am J Physiol Renal Physiol Date: 2014-03-12
Authors: Morgana T L Castelo-Branco; Igor D P Soares; Daiana V Lopes; Fernanda Buongusto; Cesonia A Martinusso; Alyson do Rosario; Sergio A L Souza; Bianca Gutfilen; Lea Mirian B Fonseca; Celeste Elia; Kalil Madi; Alberto Schanaider; Maria Isabel D Rossi; Heitor S P Souza Journal: PLoS One Date: 2012-03-14 Impact factor: 3.240
Authors: May Zaw Thin; Olumide Ogunlade; Joan Comenge; P Stephen Patrick; Daniel J Stuckey; Anna L David; Mark F Lythgoe; Paul Beard; Tammy L Kalber Journal: Sci Rep Date: 2020-05-05 Impact factor: 4.379